Differences

This shows you the differences between two versions of the page.

--- biomarkers_smart_phrases [2026/04/08 03:35] – [Gyne Biomarkers] gilbert
+++ biomarkers_smart_phrases [2026/04/08 04:35] (current) – gilbert
@@ Line 1: / Line 1: @@
+====== BIOMARKERS with Identifiers (Test:ID) ======
 ===== Breast Biomarkers =====
 <WRAP div width-100%>
@@ Line 23: / Line 26: @@
 <WRAP div width-100%>
 ^ Biomarker ^ Assay Purpose ^ Drug(s) ^ Diagnostic Test ^ Test ID ^
-| **PD-L1** | **Advanced** HNSCC | Pembrolizumab | PDL1 Dako 22C3 %%PharmDX%% | {{:PDL1HNSCC22C3PEMBRO.docx | ''PDL1HNSCC22C3PEMBRO''}} |
+| **PD-L1** | **Advanced** HNSCC | Pembrolizumab | PDL1 Dako 22C3 %%PharmDX%% | [[PDL1HNSCC22C3PEMBRO.docx | PDL1HNSCC22C3PEMBRO]] |
-| **PD-L1** | **Resectable** HNSCC | Pembrolizumab as **Neoadjuvant** | PDL1 Dako 22C3 %%PharmDX%% | {{:PDL1HNSCCNEOADPEMBRO.docx | ''PDL1HNSCCNEOADPEMBRO''}} |
+| **PD-L1** | **Resectable** HNSCC | Pembrolizumab as **Neoadjuvant** | PDL1 Dako 22C3 %%PharmDX%% | [[PDL1HNSCCNEOADPEMBRO.docx | PDL1HNSCCNEOADPEMBRO]] |
 </WRAP>
@@ Line 31: / Line 34: @@
 <WRAP div width-100%>
 ^ Biomarker ^ Assay Purpose ^ Drug(s) ^ Diagnostic Test ^ Test ID ^
-| **PD-L1** | NSCLC stage IIIb to IV | Pembrolizumab | PDL1 22C3 | {{:PDL1NSCLCPEMBRO22C3.docx | ''PDL1NSCLCPEMBRO22C3''}} |
+| **PD-L1** | NSCLC stage IIIb to IV | Pembrolizumab | PDL1 22C3 | [[PDL1NSCLCPEMBRO22C3.docx | PDL1NSCLCPEMBRO22C3]] |
-| **PD-L1** | NSCLC stage II to IIIA | Atezolizumab as **Adjuvant** | PDL1 SP263 | {{:PDL1NSCLCATEZOSP263.docx | ''PDL1NSCLCATEZOSP263''}} |
+| **PD-L1** | NSCLC stage II to IIIA | Atezolizumab as **Adjuvant** | PDL1 SP263 | [[PDL1NSCLCATEZOSP263.docx | PDL1NSCLCATEZOSP263]] |
+| **ALK** | NSCLC | alectinib, lorlatinib | ALK OTI1A4 | [[LUALKNEW.docx | LUALKNEW]] |
 </WRAP>
+===== Agnostic Biomarkers and miscellaneous =====
+<WRAP div width-100%>
+^ Biomarker ^ Assay Purpose ^ Drug(s) ^ Diagnostic Test ^ Test ID ^
+| **pan-TRK** | Any primary | TRK inhibitors (Larotrectinib) | pan-TRK | [[PANTRK | PANTRK]] |
+| **PD-L1 IHC NON-REPORTABLE** | Any primary | NA | Any clone | [[MDHPDL1NONREPORTABLE | MDHPDL1NONREPORTABLE]] |
+</WRAP>
+[[Summary List|Summary List]]